Navigation Links
Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over
Date:3/31/2008

Lowering the blood pressure of elderly patients could cut their total mortality by a fifth and their rate of cardiovascular events by a third, according to a new study presented today at the American College of Cardiology in Chicago and published simultaneously in the New England Journal of Medicine.

LONDON, March 31 /PRNewswire/ -- The 3,845 patient Hypertension in the Very Elderly Trial (HYVET), which is co-ordinated by scientists from Imperial College London, is the largest ever clinical trial to look at the effects of lowering blood pressure solely in those aged 80 and over. Patients were given either a placebo or the diuretic indapamide slow release (SR) 1.5mg, with the addition of the ACE inhibitor perindopril in tablet form once a day.

The research shows that the benefits of treatment include a 21% (p=0.02) reduction in total mortality rate, a 39% (p=0.05) reduction in stroke mortality rate, a 64% (p<0.001) reduction in fatal and non-fatal heart failures and a 34% (p<0.001) reduction in cardiovascular events. The benefits were apparent within the first year of follow-up.

The reduction in overall mortality was a novel and unexpected result. Earlier trials had demonstrated that reducing blood pressure in the under-80s reduces stroke and cardiovascular events. However, previous smaller and inconclusive studies also suggested that whilst lowering blood pressure in those aged 80 or over reduced the number of strokes, it did not reduce, and even possibly increased, total mortality.

In July 2007 the trial was stopped early on the recommendation of an independent data monitoring committee after they observed significant reductions in overall mortality and stroke in those receiving treatment. The final results of the trial showed a significant reduction in stroke mortality rate, but the reduction in all strokes of 30% did not quite reach statistical significance (p=0.06). In those aged 80 and over, up to half of strokes are fatal and
'/>"/>

SOURCE Imperial College London
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
2. Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference
3. Exelixis Announces March 4 Webcast of Presentation at the Susquehanna SIGnificant Options in Healthcare Conference
4. InterMune to Present at the SIGnificant Options in Healthcare Conference
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
7. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
8. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
9. AMDL Receives a Significant Updated Appraisal of Its JJB China Production Facilities
10. Significant Progress Made in Nations Preparedness to Respond to Public Health Emergencies; But Gaps in Critical Areas Threaten Overall Readiness
11. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...s a research industry first, allowing veterinary r... safety study data to be managed in one software a...s, NJ (PRWEB) November 9, 2009 -- Xybion Medical S...ma™ VM, an integrated enterprise software so...and care of veterinary research subjects. Pristima...
(Date:11/8/2009)...9 Complete Genomics, a third-generation human gen...n of a report in the journal Science describing ... analysis of sequence data from three complete hum...enomes sequenced on the proof-of-principle genomic...e to $1,726 for 45x coverage for the samples descr...
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...wswire/ -- EUCODIS Bioscience, a company,developin...es for the,chemical industry announced today that ...Sidus, the leading biopharmaceutical company in La...S Bioscience exclusive access - for the search,of ...llection of,psychrophilic bacteria strains and oth...
Breaking Biology Technology:Xybion Unveils Pristima&#8482; VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2
...therapy reversed hemophilia in mice , , GAITHERSB... today the publication of a new research article, ...nscripts for Production of Therapeutic Proteins I... study describes a novel RNA therapy technique in ...lbumin gene "hijacks" the albumin, causing it to p...
...LE, Ariz., April 6 MedTrust Online, announced tod...l Research Institute (SCRI) at Scottsdale Healthca...e knowledge discovery and collaboration tools at ...ill enable more access to the latest therapies to ...nt for physicians to find and communicate with eac...
... ACI EUROPE, CANSO, EUROCONTROL an...duce the CO2 emitted by aircraft in Europe by over... Geneva, Switzerland (PRWEB) April 6, 2009 ...d a joint action plan designed to reduce the CO2 e...n tonnes a year., , , , ,The plan, launched at the...
Other Biology Technology:VIRxSYS Publishes New Study on RNA Therapy 2MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care 2Aviation partners to cut 500,000 tonnes of CO2 a year 2
(Date:11/9/2009)...gists have had their hands tied because more than ...ble a protein called p53. As a critical anti-cance...g operations within cells. When cells lose p53, tu.... , These tumors might be tough, but they,re no...g Harbor Laboratory (CSHL). The chink in the tumor...
(Date:11/9/2009)...ngs has inspired a 3.2m, three-year research proje...ds of security, energy and the environment. The Un...mpany QinetiQ have just signed a collaborative con...reaking physical sciences research. , Over the ...versity of Exeter and QinetiQ will work together t...
(Date:11/9/2009)... A nutritionist whose research was instrumental in..., Infants and Children (WIC) food subsidy will rec...tstanding achievement in the field of maternal-fet... professor in the Department of Community Health S...es School of Public Health, will receive the award...
Breaking Biology News(10 mins):CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Older Women May Sleep Better Than Men 58638 1Older Women May Sleep Better Than Men 58638 2Heart Pacing Devices Hold Promise for Heart Failure 58636 1Heart Pacing Devices Hold Promise for Heart Failure 58636 2
...N, N.J. Katherine Freed, undergraduate at Stevens...nternational ISPE Undergraduate Poster Contest in ...mpetitor from New Jersey to win this ISPE award. H...d on a project she created with her Senior Design ...gional ISPE Poster Contest was hosted by the Steve...
... release is available in Spanish . , Idiopathic ... with a very severe prognosis; when detected, it i... from it cannot develop with normality pulmonary g...fe. Because of lack of an effective treatment, the...iopathic pulmonary fibrosis affects 13 out of 100,...
...svirus May Play Role in Central Nervous System Dis...esting a herpesvirus may be responsible for some c...from the New York State Department of Public Healt...n the December 2007 issue of the Journal of Clinic... one of the most prevalent in humans. There are t...
Other Biology News:Katherine Freed wins first place at the International ISPE Undergraduate Poster Contest 2Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3
QIAshredder (50) from QIAGEN
...I 1640 medium with 2 mM L-glutamine and harvested ...antigens in their native forms, cells were fixed i...-well (5 mm) adhesive coated slide, with each well... attachment and to minimize background staining. ...
...PMI 1640 with 2 mM L-glutamine and harvested at th...ens in their native forms, cells were fixed in ace... (5 mm) adhesive coated slide, with each wells sur...chment and to minimize background staining. Each ...
Mouse Anti-Human XPMC2H Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: